Heart Failure Medication Titration Plan

← Back to document page

Heart F AILURE (HF) Medication OPTIMISATION - 08/2022DO NOT WRITE IN THIS BINDING MARGINPage 1 of 2URN:Family name:Given name(s):Address:Date of birth: Sex: M F IHeart Failure (HF) MedicationOptimisation Plan State of Queensland (Queensland Health) 2022Licensed under: : ........................................ ........................................ ......................... Dear ........................................ ........................................ ........................................ ........................................ ........................................ ....................................Pl ea se op timise this patie nt s he art fai lure med ic ationsandcall the n umber below if there are an y sultsEF %:Date Wei ght (kg)eGFR mL/minK+ mmol /LBP mmHgHR bpmMonit oring recommendations(see overl eaffor guid ance) Checkbl ood pr essure(BP) inc lu dingposturaldrop andhe art rate (HR)eachvisit ACEI/ARB/ARNI/ MRA*: check serum potassiu m (K+), renal function 1-2 week/s after commenci ng or titrating(if K+ is high recheck in 48 hou rs).

In heart failure with reduced ejection fraction (HFrEF) the following medications can reduce morbidity and mortality when titrated to maximum tolerated dose: i) angiotensin-converting-enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) or

  Earth, With, Failure, Reduced, Heart failure, Ejection, Heart failure with reduced ejection